Clinical trial
Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function
NCT00189085 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00189085 |
|---|---|
| Title | Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function |
| Official title | The Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Dysfunction in Patients With the Metabolic Syndrome. |
| Lead sponsor | UMC Utrecht, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | simvastatin and ezetimibe |
| Enrollment | 20 |
| Start date | Dec 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 10, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: